| Year |
Citation |
Score |
| 2024 |
Kumar M, Quittot N, Dujardin S, Schlaffner CN, Viode A, Wiedmer A, Beerepoot P, Chun JE, Glynn C, Fernandes AR, Donahue C, Steen JA, Hyman BT. Alzheimer proteopathic tau seeds are biochemically a forme fruste of mature paired helical filaments. Brain : a Journal of Neurology. PMID 38236720 DOI: 10.1093/brain/awad378 |
0.858 |
|
| 2023 |
Welikovitch LA, Dujardin S, Dunn AR, Fernandes AR, Khasnavis A, Chibnik LB, Kaczorowski CC, Hyman BT. Rate of tau propagation is a heritable disease trait in genetically diverse mouse strains. Iscience. 26: 105983. PMID 36756365 DOI: 10.1016/j.isci.2023.105983 |
0.839 |
|
| 2022 |
Dujardin S, Fernandes A, Bannon R, Commins C, De Los Santos M, Kamath TV, Hayashi M, Hyman BT. Tau propagation is dependent on the genetic background of mouse strains. Brain Communications. 4: fcac048. PMID 35350555 DOI: 10.1093/braincomms/fcac048 |
0.851 |
|
| 2021 |
Petrozziello T, Amaral AC, Dujardin S, Farhan SMK, Chan J, Trombetta BA, Kivisäkk P, Mills AN, Bordt EA, Kim SE, Dooley PM, Commins C, Connors TR, Oakley DH, Ghosal A, et al. Novel genetic variants in MAPT and alterations in tau phosphorylation in amyotrophic lateral sclerosis post-mortem motor cortex and cerebrospinal fluid. Brain Pathology (Zurich, Switzerland). e13035. PMID 34779076 DOI: 10.1111/bpa.13035 |
0.803 |
|
| 2021 |
Petrozziello T, Bordt EA, Mills AN, Kim SE, Sapp E, Devlin BA, Obeng-Marnu AA, Farhan SMK, Amaral AC, Dujardin S, Dooley PM, Henstridge C, Oakley DH, Neueder A, Hyman BT, et al. Targeting Tau Mitigates Mitochondrial Fragmentation and Oxidative Stress in Amyotrophic Lateral Sclerosis. Molecular Neurobiology. PMID 34757590 DOI: 10.1007/s12035-021-02557-w |
0.766 |
|
| 2021 |
Fernandes AR, Dujardin S, Maté de Gérando A, Hyman BT, Frosch MP. Impact of Sterilization Methods on the Seeding Ability of Human Tau Proteopathic Seeds. Journal of Neuropathology and Experimental Neurology. PMID 34498073 DOI: 10.1093/jnen/nlab087 |
0.846 |
|
| 2021 |
Kamath TV, Klickstein N, Commins C, Fernandes AR, Oakley DH, Frosch MP, Hyman BT, Dujardin S. Kinetics of tau aggregation reveals patient-specific tau characteristics among Alzheimer's cases. Brain Communications. 3: fcab096. PMID 34222869 DOI: 10.1093/braincomms/fcab096 |
0.814 |
|
| 2021 |
Cooper JM, Lathuiliere A, Migliorini M, Arai AL, Wani MM, Dujardin S, Muratoglu SC, Hyman BT, Strickland DK. Regulation of tau internalization, degradation, and seeding by LRP1 reveals multiple pathways for tau catabolism. The Journal of Biological Chemistry. 100715. PMID 33930462 DOI: 10.1016/j.jbc.2021.100715 |
0.675 |
|
| 2021 |
Oakley DH, Klickstein N, Commins C, Chung M, Dujardin S, Bennett RE, Hyman BT, Frosch MP. Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 33893219 DOI: 10.1523/JNEUROSCI.2590-20.2021 |
0.833 |
|
| 2021 |
Dujardin S, Commins C, Lathuiliere A, Beerepoot P, Fernandes AR, Kamath TV, De Los Santos MB, Klickstein N, Corjuc DL, Corjuc BT, Dooley PM, Viode A, Oakley DH, Moore BD, Mullin K, et al. Author Correction: Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease. Nature Medicine. PMID 33514949 DOI: 10.1038/s41591-021-01251-7 |
0.796 |
|
| 2020 |
Sepulveda-Falla D, Chavez-Gutierrez L, Portelius E, Vélez JI, Dujardin S, Barrera-Ocampo A, Dinkel F, Hagel C, Puig B, Mastronardi C, Lopera F, Hyman BT, Blennow K, Arcos-Burgos M, de Strooper B, et al. A multifactorial model of pathology for age of onset heterogeneity in familial Alzheimer's disease. Acta Neuropathologica. PMID 33319314 DOI: 10.1007/s00401-020-02249-0 |
0.661 |
|
| 2020 |
Wesseling H, Mair W, Kumar M, Schlaffner CN, Tang S, Beerepoot P, Fatou B, Guise AJ, Cheng L, Takeda S, Muntel J, Rotunno MS, Dujardin S, Davies P, Kosik KS, et al. Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer's Disease. Cell. PMID 33188775 DOI: 10.1016/j.cell.2020.10.029 |
0.65 |
|
| 2020 |
Perez-Rando M, Dujardin S, Bennett RE, Commins C, Nibhanupudy T, Hyman BT. Synaptic and metabolic gene expression alterations in neurons that are recipients of proteopathic tau seeds. Acta Neuropathologica Communications. 8: 168. PMID 33076986 DOI: 10.1186/s40478-020-01049-7 |
0.754 |
|
| 2020 |
Bennett RE, Hu M, Fernandes A, Perez-Rando M, Robbins A, Kamath T, Dujardin S, Hyman BT. Tau reduction in aged mice does not impact Microangiopathy. Acta Neuropathologica Communications. 8: 137. PMID 32811565 DOI: 10.1186/S40478-020-01014-4 |
0.832 |
|
| 2020 |
Dujardin S, Commins C, Lathuiliere A, Beerepoot P, Fernandes AR, Kamath TV, De Los Santos MB, Klickstein N, Corjuc DL, Corjuc BT, Dooley PM, Viode A, Oakley DH, Moore BD, Mullin K, et al. Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease. Nature Medicine. PMID 32572268 DOI: 10.1038/S41591-020-0938-9 |
0.805 |
|
| 2020 |
Kamath TV, Commins C, Klickstein N, Oakley D, Hyman BT, Dujardin S. Employing an
in vitro
biosensor assay to investigate tau seeding kinetics within cases of sporadic Alzheimer disease and in a model of tauopathy Alzheimer's & Dementia. 16. DOI: 10.1002/alz.047169 |
0.834 |
|
| 2020 |
Dujardin S, De Los Santos M, Fernandes AR, Bannon RN, Kamath TV, Commins C, Hyman BT. Tau propagation is dependent on the genetic background in multiple mouse strains Alzheimer's & Dementia. 16. DOI: 10.1002/alz.043059 |
0.793 |
|
| 2019 |
Dujardin S, Hyman BT. Tau Prion-Like Propagation: State of the Art and Current Challenges. Advances in Experimental Medicine and Biology. 1184: 305-325. PMID 32096046 DOI: 10.1007/978-981-32-9358-8_23 |
0.632 |
|
| 2019 |
Hanlon KS, Meltzer JC, Buzhdygan T, Cheng MJ, Sena-Esteves M, Bennett RE, Sullivan TP, Razmpour R, Gong Y, Ng C, Nammour J, Maiz D, Dujardin S, Ramirez SH, Hudry E, et al. Selection of an Efficient AAV Vector for Robust CNS Transgene Expression. Molecular Therapy. Methods & Clinical Development. 15: 320-332. PMID 31788496 DOI: 10.1016/J.Omtm.2019.10.007 |
0.589 |
|
| 2019 |
Calvo-Rodriguez M, Hou SS, Snyder AC, Dujardin S, Shirani H, Nilsson KPR, Bacskai BJ. In vivo detection of tau fibrils and amyloid β aggregates with luminescent conjugated oligothiophenes and multiphoton microscopy. Acta Neuropathologica Communications. 7: 171. PMID 31703739 DOI: 10.1186/S40478-019-0832-1 |
0.381 |
|
| 2019 |
Colin M, Dujardin S, Schraen-Maschke S, Meno-Tetang G, Duyckaerts C, Courade JP, Buée L. From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy. Acta Neuropathologica. PMID 31686182 DOI: 10.1007/S00401-019-02087-9 |
0.847 |
|
| 2019 |
Eftekharzadeh B, Daigle JG, Kapinos LE, Coyne A, Schiantarelli J, Carlomagno Y, Cook C, Miller SJ, Dujardin S, Amaral AS, Grima JC, Bennett RE, Tepper K, DeTure M, Vanderburg CR, et al. Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease. Neuron. 101: 349. PMID 30653936 DOI: 10.1016/J.Neuron.2018.12.031 |
0.827 |
|
| 2019 |
Busche MA, Wegmann S, Dujardin S, Commins C, Schiantarelli J, Klickstein N, Kamath TV, Carlson GA, Nelken I, Hyman BT. Tau impairs neural circuits, dominating amyloid-β effects, in Alzheimer models in vivo. Nature Neuroscience. 22: 57-64. PMID 30559471 DOI: 10.1038/S41593-018-0289-8 |
0.835 |
|
| 2019 |
Dujardin S, Commins C, Kamath TV, De Los Santos M, Dooley PM, Moore BD, Jean-Gilles D, Clark R, Kennedy M, Hyman BT. RELEVANCE OF TAU SEEDING FOR THE CLINICAL HETEROGENEITY OF ALZHEIMER’S DISEASE: IMPLICATION FOR THERAPEUTIC PERSPECTIVES Alzheimer's & Dementia. 15: P1623. DOI: 10.1016/J.Jalz.2019.06.4854 |
0.801 |
|
| 2018 |
Dujardin S, Bégard S, Caillierez R, Lachaud C, Carrier S, Lieger S, Gonzalez JA, Deramecourt V, Déglon N, Maurage CA, Frosch MP, Hyman BT, Colin M, Buée L. Different tau species lead to heterogeneous tau pathology propagation and misfolding. Acta Neuropathologica Communications. 6: 132. PMID 30497516 DOI: 10.1186/S40478-018-0637-7 |
0.86 |
|
| 2018 |
Eftekharzadeh B, Daigle JG, Kapinos LE, Coyne A, Schiantarelli J, Carlomagno Y, Cook C, Miller SJ, Dujardin S, Amaral AS, Grima JC, Bennett RE, Tepper K, DeTure M, Vanderburgh CR, et al. Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease. Neuron. 99: 925-940.e7. PMID 30189209 DOI: 10.1016/J.Neuron.2018.07.039 |
0.874 |
|
| 2018 |
DeVos SL, Corjuc BT, Commins C, Dujardin S, Bannon RN, Corjuc D, Moore BD, Bennett RE, Jorfi M, Gonzales JA, Dooley PM, Roe AD, Pitstick R, Irimia D, Frosch MP, et al. Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo. Brain : a Journal of Neurology. PMID 29733334 DOI: 10.1093/Brain/Awy117 |
0.798 |
|
| 2018 |
Wegmann S, Eftekharzadeh B, Tepper K, Zoltowska KM, Bennett RE, Dujardin S, Laskowski PR, MacKenzie D, Kamath T, Commins C, Vanderburg C, Roe AD, Fan Z, Molliex AM, Hernandez-Vega A, et al. Tau protein liquid-liquid phase separation can initiate tau aggregation. The Embo Journal. PMID 29472250 DOI: 10.15252/Embj.201798049 |
0.864 |
|
| 2017 |
Mudher A, Colin M, Dujardin S, Medina M, Dewachter I, Naini SMA, Mandelkow EM, Mandelkow E, Buée L, Goedert M, Brion JP. What is the evidence that tau pathology spreads through prion-like propagation? Acta Neuropathologica Communications. 5: 99. PMID 29258615 DOI: 10.1186/S40478-017-0488-7 |
0.848 |
|
| 2017 |
Bennett RE, DeVos SL, Dujardin S, Corjuc B, Gor R, Gonzalez J, Roe AD, Frosch MP, Pitstick R, Carlson GA, Hyman BT. Enhanced Tau Aggregation in the Presence of Amyloid β. The American Journal of Pathology. PMID 28500862 DOI: 10.1016/J.Ajpath.2017.03.011 |
0.819 |
|
| 2017 |
Colin M, Tardivel M, Bégard S, Bousset L, Dujardin S, Richetin K, Deglon N, Melki R, Buee L. Tau Spreading: How Are Tau Assemblies Transferred From Cell To Cell? Alzheimers & Dementia. 13: 906. DOI: 10.1016/J.Jalz.2017.07.320 |
0.788 |
|
| 2016 |
Tardivel M, Bégard S, Bousset L, Dujardin S, Coens A, Melki R, Buée L, Colin M. Tunneling nanotube (TNT)-mediated neuron-to neuron transfer of pathological Tau protein assemblies. Acta Neuropathologica Communications. 4: 117. PMID 27809932 DOI: 10.1186/S40478-016-0386-4 |
0.808 |
|
| 2016 |
Buee L, Dujardin S, Tardivel M, Begard S, Caillierez R, Bousset L, Melki R, Colin M. The ins and outs of tau propagation Neurobiology of Aging. 39. DOI: 10.1016/J.Neurobiolaging.2016.01.071 |
0.817 |
|
| 2015 |
Dujardin S, Colin M, Buée L. Invited review: Animal models of tauopathies and their implications for research/translation into the clinic. Neuropathology and Applied Neurobiology. 41: 59-80. PMID 25428793 DOI: 10.1111/Nan.12200 |
0.802 |
|
| 2015 |
Buee L, Colin M, Dujardin S, Badin RA, Bemelmans A, Jan C, Camp NV, Deglon N, Hantraye P. Non-human primate model of tauopathy Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.07.060 |
0.685 |
|
| 2014 |
Dujardin S, Bégard S, Caillierez R, Lachaud C, Delattre L, Carrier S, Loyens A, Galas MC, Bousset L, Melki R, Aurégan G, Hantraye P, Brouillet E, Buée L, Colin M. Ectosomes: a new mechanism for non-exosomal secretion of tau protein. Plos One. 9: e100760. PMID 24971751 DOI: 10.1371/Journal.Pone.0100760 |
0.814 |
|
| 2014 |
Dujardin S, Lécolle K, Caillierez R, Bégard S, Zommer N, Lachaud C, Carrier S, Dufour N, Aurégan G, Winderickx J, Hantraye P, Déglon N, Colin M, Buée L. Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies. Acta Neuropathologica Communications. 2: 14. PMID 24479894 DOI: 10.1186/2051-5960-2-14 |
0.836 |
|
| 2014 |
Dujardin S, Brouillet E, Hantraye P, Colin M, Buée L. Which Tau species are toxic? Consequences for therapeutic approaches Neurobiology of Aging. 35: S4. DOI: 10.1016/J.Neurobiolaging.2014.01.042 |
0.763 |
|
| 2013 |
Caillierez R, Bégard S, Lécolle K, Deramecourt V, Zommer N, Dujardin S, Loyens A, Dufour N, Aurégan G, Winderickx J, Hantraye P, Déglon N, Buée L, Colin M. Lentiviral delivery of the human wild-type tau protein mediates a slow and progressive neurodegenerative tau pathology in the rat brain. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1358-68. PMID 23609018 DOI: 10.1038/Mt.2013.66 |
0.834 |
|
| 2013 |
Buee L, Dujardin S, Bégard S, Raphaëlle C, Lécolle K, Dufour N, Auregan G, Winderickx J, Philippe H, Deglon N, Colin M. In vivo tau spreading relies on the transsynaptic transfer of soluble wild-type tau species Alzheimers & Dementia. 9: 142. DOI: 10.1016/J.Jalz.2013.04.090 |
0.795 |
|
| 2012 |
Deramecourt V, Lebert F, Maurage CA, Fernandez-Gomez FJ, Dujardin S, Colin M, Sergeant N, Buée-Scherrer V, Clot F, Ber IL, Brice A, Pasquier F, Buée L. Clinical, neuropathological, and biochemical characterization of the novel tau mutation P332S. Journal of Alzheimer's Disease : Jad. 31: 741-9. PMID 22699846 DOI: 10.3233/Jad-2012-120160 |
0.767 |
|
| Show low-probability matches. |